In addition to its well-characterized role in the immune response and lymphoid malignancies, several studies have linked c-Rel to the progression of epithelial cancers, including prostate, breast, and head and neck cancer [23], [37], [38], [39]. This evidence concerns the gene REL and head and neck cancer.